Treatment of uterine prolapse

Uterine prolapse is a form of pelvic organ prolapse in which the uterus descends from its normal pelvic position into the vaginal canal because of weakness or injury to the pelvic floor support structures. It is a common condition among parous and postmenopausal women and can range from asymptomatic descent detected at examination to severe prolapse associated with bothersome pressure, urinary and bowel symptoms, and impaired quality of life.

This article reviews the causes, evaluation, conservative and surgical treatment options for uterine prolapse, with guidance on prevention, postoperative expectations and when to seek specialist care. Information is based on current clinical recommendations and patient resources from major authorities (ACOG, NIH/MedlinePlus, Mayo Clinic, Cleveland Clinic).

Anatomy and pathophysiology

The uterus is supported in the pelvis by a complex combination of pelvic floor muscles (primarily the levator ani complex), connective tissue ligaments (uterosacral, cardinal ligaments), and the vaginal walls. Damage to any component — by childbirth trauma, repetitive increased intra‑abdominal pressure, connective tissue disorders, or the estrogen‑related changes of menopause — can allow the uterus and/or vaginal walls to descend.

Prolapse reflects a failure of support rather than a disease of the uterus itself. The degree of descent varies; symptoms depend on severity, organ involvement (anterior, apical, posterior compartments), and associated urinary or bowel dysfunction.

Risk factors

Common risk factors for uterine prolapse include:

Vaginal childbirth, especially prolonged second stage or instrumental deliveries and large babies. Vaginal delivery is the most consistent risk factor.
Age and menopause: estrogen deficiency leads to atrophy and decreased strength of pelvic tissues.
Chronic increases in intra‑abdominal pressure such as chronic coughing, heavy lifting, and constipation/straining.
Obesity.
Connective tissue disorders and genetic predisposition to weakened pelvic support.
Prior pelvic surgery that disrupts support structures.
Multiparity (multiple vaginal births).

(References: ACOG; Mayo Clinic; Cleveland Clinic)

Symptoms

Symptoms of uterine prolapse may include:

A sensation of pelvic pressure, heaviness, or “something falling out.”
A bulge or tissue protruding from the vaginal opening in more advanced cases.
Urinary symptoms: frequency, urgency, incomplete emptying, stress urinary incontinence, or recurrent urinary tract infections.
Bowel symptoms: difficulty with bowel movements, need to digitally assist defecation if a posterior prolapse (rectocele) is present.
Sexual dysfunction or discomfort with intercourse.

Some women remain asymptomatic despite anatomic prolapse detected on exam.

Staging and classification

Multiple grading systems exist. The Pelvic Organ Prolapse Quantification system (POP‑Q) is the standardized system used in many clinical settings; it quantifies descent at specific vaginal points and stages prolapse from 0 (no prolapse) to IV (complete eversion). Simpler descriptive gradings (I–III) are still encountered: mild (within the vagina), moderate (to or beyond the introitus), and severe (complete prolapse).

Accurate staging guides treatment decisions and enables objective monitoring over time.

Evaluation

A focused evaluation is performed by a clinician experienced in pelvic floor disorders and includes:

Comprehensive history: onset and progression of symptoms, obstetric history, urinary and bowel symptoms, sexual function, prior pelvic surgery, comorbidities (chronic cough, constipation, obesity), and impact on quality of life.
Physical examination: standing and supine pelvic examination, assessment of prolapse with Valsalva (bearing down), evaluation of urethral mobility, pelvic floor muscle tone, and check for other pelvic organ prolapse (bladder, rectum). A pelvic exam may be performed with a speculum.
Optional measurements: POP‑Q staging for documentation.
Urinalysis to exclude infection if urinary symptoms present.
Post‑void residual measurement if incomplete emptying is suspected.
Further testing (urodynamics, imaging) reserved for complex cases or where concomitant urinary dysfunction will affect surgical planning.

Most diagnoses are clinical and do not require imaging. Referral to a urogynecologist or pelvic floor physical therapist is appropriate when symptoms are bothersome or management beyond lifestyle measures is being considered.

(References: ACOG; Mayo Clinic)

Goals of treatment

Treatment focuses on:

Relief of symptoms and improvement in quality of life.
Restoration or support of pelvic anatomy as needed.
Correction of associated urinary or bowel dysfunction.
Minimizing treatment risks and preserving function important to the patient (including sexual function and, when desired, uterine preservation).

Treatment must be individualized according to symptom severity, stage of prolapse, comorbidities, age, sexual function, desire for future fertility, and patient preference.

Conservative (non‑surgical) management

Conservative therapies are first‑line for women with mild to moderate prolapse, for those who are poor surgical candidates, or for women who prefer to avoid or delay surgery.

Pelvic floor muscle training (PFMT, “Kegels”)

Strengthening the pelvic floor with regular, targeted exercises is an evidence‑based approach for symptomatic mild to moderate prolapse and can reduce symptoms and improve support.

Key points for PFMT:

Technique: The pelvic floor muscles are contracted as if trying to stop the flow of urine or prevent passage of gas — a gentle lift and squeeze. A short contraction (1–2 seconds) and a longer contraction (5–10 seconds) combined with relaxation are typically taught. It is important to avoid substituting abdominal, gluteal or thigh muscles.
Dosage: Programs often prescribe several sets per day (for example, 3 sets of 8–12 contractions, with both long and short holds), progressed over months. Supervision by a pelvic floor physical therapist improves technique, adherence and outcomes.
Caution: Repeatedly stopping the urine stream as a training method is not recommended as a regular exercise technique because it may promote urinary retention and infection; it can be used once to identify the correct muscles but not as a routine exercise.
Adjuncts: Biofeedback and electrical stimulation may help women who cannot voluntarily contract or who need help learning proper technique.

Pelvic floor muscle training has been shown to reduce prolapse symptoms and delay or reduce the need for surgery in many women.

(References: ACOG; NIH)

Pelvic floor physical therapy

Pelvic floor physical therapists provide individualized training, manual therapy, biofeedback, and behavioral strategies to optimize pelvic floor function. They can address coexisting musculoskeletal contributors such as pelvic pain or abnormal muscle guarding.

Referral to an experienced pelvic floor physiotherapist is recommended when initial training is unsuccessful or when more hands‑on rehabilitation is needed.

Vaginal pessaries

A pessary is a removable medical device placed in the vagina to support pelvic organs. Pessaries are effective for symptom relief across a range of prolapse stages and are often used when:

The patient desires non‑surgical management or wants pregnancy in the future, or
Surgery is contraindicated or delayed for medical reasons.

Types and key considerations:

Available in different shapes (ring, donut, cube) and sizes; fitting is individualized by a clinician.
Patients or clinicians can remove and clean the pessary; some women wear them continuously with periodic clinic follow‑up, others remove nightly.
Vaginal topical estrogen may be prescribed concurrently for postmenopausal women to reduce irritation and improve tissue health.
Risks: vaginal discharge, odor, local irritation, ulceration if left in without care—regular follow‑up is essential.

Pessaries provide immediate symptom relief and are a reversible option.

(References: Mayo Clinic; Cleveland Clinic)

Hormone therapy (topical estrogen)

Local (topical) vaginal estrogen can improve the quality of atrophic vaginal tissues in postmenopausal women, potentially reducing symptoms such as irritation and making pessary use more comfortable. Systemic hormone therapy is not indicated solely to treat prolapse and has limited effect on established anatomic prolapse.

Topical estrogen is used cautiously and in accordance with available contraindications and patient preferences.

Lifestyle measures

Simple measures can slow progression and decrease symptoms:

Manage chronic constipation through fiber, fluids, stool softeners when appropriate, and avoidance of straining.
Reduce intra‑abdominal pressure: treat chronic cough, avoid heavy and repetitive lifting, and modify activities that provoke symptoms.
Weight management: weight loss can lessen downward pressure on pelvic floor support.
Smoking cessation (reduces chronic cough and improves tissue health).

These measures complement PFMT and other treatments.

Surgical management

Surgery is considered when conservative measures are ineffective, when prolapse is severe or symptomatic, or when an anatomical repair is desired. Surgical objectives include restoring normal vaginal and uterine/pelvic support, addressing concurrent pelvic organ defects, and treating associated urinary symptoms where appropriate.

Decision‑making should be individualized and performed with a clinician who discusses options, benefits, risks, and the patient’s values.

General principles:

Consideration of uterine preservation versus hysterectomy. Uterine‑sparing procedures are appropriate for some women who wish to retain their uterus and do not have uterine pathology that requires removal.
Selection of approach (vaginal, abdominal open, laparoscopic, robotic) depends on surgeon expertise, patient anatomy, and concomitant procedures.
Use of mesh: synthetic mesh grafts have been used to reinforce repairs, particularly for apical prolapse; however, transvaginal mesh placement has been associated with higher rates of mesh complications (erosion, pain) leading to regulatory warnings and changes in practice. Abdominal sacrocolpopexy with mesh remains a commonly used and effective approach for vaginal vault or apical support, but mesh use requires informed consent about potential complications.

(References: ACOG; Mayo Clinic; FDA communications summarized by professional societies)

Common surgical procedures

Vaginal hysterectomy with uterosacral or sacrospinous ligament suspension: removal of the uterus via the vagina with reconstruction to support the vaginal apex. This is a traditional approach for symptomatic uterine prolapse.
Uterus‑sparing procedures (sacrohysteropexy or hysteropexy): fixation of the uterus to the sacrum or ligaments using native tissue or mesh through an abdominal, laparoscopic or robotic approach. These procedures preserve the uterus and may be preferred by some patients.
Sacrocolpopexy: typically performed abdominally or laparoscopically with mesh attachment from the vaginal cuff to the sacral promontory, providing durable apical support—used when the uterus has been removed or after combined procedures.
Anterior and/or posterior colporrhaphy: repair of cystocele (anterior wall) or rectocele (posterior wall) often performed at the time of apical suspension.
Obliterative procedures (e.g., Le Fort colpocleisis): partial closure of the vaginal canal to obliterate prolapse; suitable for women who are not sexually active and do not desire vaginal intercourse in the future; these procedures are less invasive and have high rates of symptom relief.

Risks and outcomes

All surgeries carry risks: bleeding, infection, anesthesia complications, urinary tract injury, recurrence of prolapse, and new or persistent urinary or bowel symptoms. Mesh‑related complications (if mesh is used) include erosion/exposure, pain, and the potential need for further surgery.

Recurrence rates vary by procedure, patient factors, and surgeon experience. Many women experience significant symptom relief and improved quality of life after appropriate surgical management.

Shared decision‑making with a pelvic floor specialist is crucial to select the best approach, balancing durability, recovery, and potential complications.

(References: ACOG; Cleveland Clinic)

Postoperative care and recovery

Recovery time varies with surgical approach: vaginal and minimally invasive laparoscopic/robotic procedures typically have shorter hospital stays and faster recovery than open abdominal operations.
Activity restrictions (avoiding heavy lifting and straining) are advised for several weeks to allow healing; pelvic rest is usually recommended for a period if reconstructive work was performed.
Pelvic floor exercises often continue after surgery to maintain support.
Follow‑up examinations evaluate wound healing, vaginal support and function. Any new symptoms (fever, significant bleeding, worsening urinary retention, severe pain) should prompt immediate contact with the care team.

Discuss expectations for recovery, symptom resolution, and the timeline for return to work and exercise with your surgeon.

Special considerations

Fertility and childbearing

Women who desire future pregnancy should discuss options with their provider. Certain uterus‑sparing procedures may permit future pregnancy, but pregnancy itself increases the risk of recurrent prolapse, and delivery mode may affect outcomes; individualized counseling is necessary.

Sexual function

Prolapse and its treatments can affect sexual function. Some surgical repairs may improve discomfort and sexual satisfaction by alleviating bulge symptoms, while others may cause dyspareunia. Preoperative counseling and selection of appropriate procedure (including consideration of uterus preservation) are important.

When to seek care

See a clinician if you experience:

A sensation of a vaginal bulge, pelvic pressure or tissue protrusion.
New or worsening urinary symptoms (urgency, incontinence, difficulty emptying).
Difficulties with bowel movements requiring digital assistance.
Vaginal bleeding or discharge, pain, or any acute concerns.

If prolapse is diagnosed, timely evaluation enables discussion of conservative measures and, if necessary, planning for intervention.

Prevention

While not all cases are preventable, risk may be reduced by:

Pelvic floor muscle training after childbirth and with advancing age.
Maintaining a healthy weight.
Avoiding chronic straining and managing constipation.
Smoking cessation to reduce chronic cough and improve tissue health.
Safe lifting techniques and avoiding repetitive heavy lifting.

Early postpartum pelvic floor rehabilitation and awareness of pelvic floor health can mitigate long‑term symptoms.

Prognosis

Many women with mild prolapse benefit from conservative measures and ongoing pelvic floor training. For symptomatic or advanced prolapse, appropriate pessary use or surgical repair can substantially improve symptoms and quality of life. Recurrence is possible, and some patients may require additional procedures over time.

Long‑term follow‑up and adherence to recommended lifestyle and pelvic floor measures contribute to durable outcomes.

Patient counseling and shared decision‑making

Management should be individualized. Clinicians should discuss:

The severity of prolapse and its impact on daily life.
All appropriate options (observation, pelvic floor therapy, pessary, surgery), expected benefits and limitations.
The potential need to treat related conditions (urinary incontinence, rectocele) at the same time.
Risks specific to surgical choices, including mesh‑related issues if applicable.
Patient preferences regarding uterine preservation, sexual function, and future fertility.

Evidence supports offering pelvic floor muscle training and pessary fitting as initial options for many women; surgery is reserved for persistent symptoms, advanced prolapse, or patient preference.

Resources and further reading

Authoritative sources and patient education pages provide accessible, up‑to‑date information on diagnosis and management:

American College of Obstetricians and Gynecologists (ACOG) — patient resources on pelvic organ prolapse and practice guidance for clinicians.
National Institutes of Health / MedlinePlus — overview of pelvic organ prolapse and treatment options.
Mayo Clinic — patient information on uterine prolapse symptoms, causes and treatments.
Cleveland Clinic — educational materials on pelvic organ prolapse, pessaries, and surgical options.

(Selected resources: ACOG; NIH/MedlinePlus; Mayo Clinic; Cleveland Clinic — links below.)

References

American College of Obstetricians and Gynecologists (ACOG). Patient FAQs and practice resources on pelvic organ prolapse. https://www.acog.org/womens-health/faqs/uterine-prolapse
MedlinePlus (U.S. National Library of Medicine / NIH). Pelvic organ prolapse. https://medlineplus.gov/ency/article/001491.htm
Mayo Clinic. Uterine prolapse — Diagnosis and treatment. https://www.mayoclinic.org/diseases-conditions/uterine-prolapse/diagnosis-treatment/drc-20375647
Cleveland Clinic. Pelvic organ prolapse (POP) — Symptoms and treatment. https://my.clevelandclinic.org/health/diseases/21652-pelvic-organ-prolapse

Note: This article is intended for educational purposes and does not replace individualized medical advice. Discuss symptoms and treatment options with your healthcare provider to determine the best plan for your situation.